Emil Kraepelin formulated the initial nosology of Alzheimer's disease in the first decade of the 20th century. Nowadays, clinical and pathological presentations (including those associated with ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion centers.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon confirm that.

Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...

15, 2025 — Regular aerobic exercise could significantly reduce disease ... to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

Alzheimer’s disease could ... Alzheimer’s disease, they would then benefit from taking new drugs that are on the market and specifically designed to treat early-stage disease.

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer’s disease in older adults. The diagnostic criteria for limbic-predominant ...

That’s just one of five things we learned about the disease this year. “In July of this year, the Alzheimer’s Association and those who are living with early-stage Alzheimer’s disease ...